Moss, AJ, Adams, FH. Heart Disease in Infants, Children, and Adolescents Including the Fetus and Young, 7th edn. Williams & Wilkins, Baltimore, MD, 2008: 632–644; 667–681.
Stein, BC, Levin, RI. Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease. Am Heart J
1998; 135: 914–923.
Berger, R, Huelsman, M, Strecker, K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation
2002; 105: 2392–2397.
Maisel, AS, Krishnaswamy, P, Nowak, RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med
2002; 347: 161–167.
de Lemos, JA, McGuire, DK, Drazner, MH. B-type natriuretic peptide in cardiovascular disease. Lancet
2003; 362: 316–322.
Kunii, Y, Kamada, M, Ohtsuki, S, et al. Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama
2003; 57: 191–197.
Oyamada, J, Toyono, M, Shimada, S, et al. Noninvasive estimation of left ventricular end-diastolic pressure using tissue Doppler imaging combined with pulsed-wave Doppler echocardiography in patients with ventricular septal defects: a comparison with the plasma levels of the B-type natriuretic peptide. Echocardiography
2008; 25: 270–277.
Ozhan, H, Albayrak, S, Uzun, H, Ordu, S, Kaya, A, Yazici, M. Correlation of plasma B-type natriuretic peptide with shunt severity in patients with atrial or ventricular septal defect. Pediatr Cardiol
2007; 28: 272–275.
Paul, MA, Backer, CL, Binns, HJ, et al. B-type natriuretic peptide and heart failure in patients with ventricular septal defect: a pilot study. Pediatr Cardiol
2009; 30: 1094–1097.
Kavga, M, Varlamis, G, Giannopoulos, A, et al. Correlation of plasma B-type natriuretic peptide with shunt volume in children with congenital heart disease involving left-to-right shunt. Hellenic J Cardiol
2013; 54: 192–198.
Schoen, SP, Zimmermann, T, Kittner, T, et al. NT-proBNP correlates with right heart haemodynamic parameters and volumes in patients with atrial septal defects. Eur J Heart Fail
2007; 9: 660–666.
Suda, K, Matsumura, M, Matsumoto, M. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int
2003; 45: 249–254.
Jan, SL, Fu, YC, Hwang, B, Lin, SJ. B-type natriuretic peptide in children with atrial or ventricular septal defect: a cardiac catheterization study. Biomarkers
2012; 17: 166–171.
Sanders, SP, Yeager, S, Williams, RG. Measurement of systemic and pulmonary blood flow and Qp/Qs ratio using Doppler and two dimensional echocardiography. Am J Cardiol
1983; 51: 952–956.
Boehrer, JD, Lange, RA, Willard, JE, Grayburn, PA, Hillis, LD. Advantages and limitations of methods to detect, localize, and quantitate intracardiac left-to-right shunting. Am Heart J
1992; 124: 448–455.
Lainchbury, JG, Campbell, E, Frampton, CM, Yandle, TG, Nicholls, MG, Richards, AM. Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol
2003; 42: 728–735.
Seino, Y, Ogawa, A, Yamashita, T, et al. Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail
2004; 6: 295–300.
Holmstrom, H, Hall, C, Thaulow, E. Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr
2001; 90: 184–191.
Leuchte, HH, Holzapfel, M, Baumgartner, RA, et al. Clinical significance of brain natriuretic peptide in primary pulmonary hypertension. J Am Coll Cardiol
2004; 43: 764–770.
Mir, TS, Marohn, S, Läer, S, et al. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics
2002; 110: e76.
Cantinotti, M, Law, Y, Vittorini, S, et al. The potential and limitations of plasma BNP measurement in the diagnosis, prognosis, and management of children with heart failure due to congenital cardiac disease: an update. Heart Fail Rev
2014; 19: 727–742.